🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

“Our findings indicate that, among patients with more recurrent C diff infection, there was a parallel trend for higher rates of colectomy and #sepsis,” the study authors wrote. hcplive.com/view/sepsis-am…

For #MedHxMonday let’s 👀 at the colon. As Dr Paul Gastro will tell you the most common area for #ischemiccolitis is the splenic flex But what’s the artery that we often forget & whose name is wrongly attributed to the father 🚫the son #HamiltonDrummond 🚫David PMCID:PMC2003096

Want to learn more about the risk factors of #Cdiffinfection? Dr Paul Gastro shares how demographics, medication, exposures, and the environment can impact risk in the Contagion video linked here. #FerringMicrobiome bit.ly/3v9ix0O

Please check out this great summary of a project that our study group recently published! #cdiff #microbiota Rates of Serious Complications Rise with Each Recurrent C difficile Infection contagionlive.com/view/rates-of-… via Contagion

#EoE is a disease that we see so often in #gastro! Check out this interview with Mena Boules, M.D. regarding the website SeeEOE.com. This is a wonderful resource for providers covering EoE! American Gastroenterological Association (AGA) ACG Healio Gastroenterology healio.com/news/gastroent…

Dealing with the impacts of #Cdiffinfection can be extremely difficult for doctors & patients. In the Contagion video linked below Dr Paul Gastro presents his opinion on how #HCPs can provide better care when it comes to C diff. #FerringMicrobiome bit.ly/3rt8BN7

RT Ferring Pharmaceuticals U.S.: Want to learn more about the risk factors of #Cdiffinfection? Dr Paul Gastro shares how demographics, medication, exposures, and the environment can impact risk in the Contagion video linked here. #FerringMicrobiome bit.ly/3v9ix0O

In today's #MicrobiomeMonday post see what Dr Paul Gastro Teena Chopra MD,MPH ,FIDSA,FSHEA and Kevin Garey have to say regarding the next frontier of #cdiff infection and recurrence in this special report on Microbiome-Based Therapy. bit.ly/3v9xSOJ #FerringMicrobiome

43% of individuals with 3 or more C. diff recurrences experienced sepsis and more than 10% required colorectal surgery. gastroendonews.com/In-the-News/Ar… Dr Paul Gastro Yale School of Medicine #Cdiff #sepsis

Our #CDiff expert panel, including Teena Chopra MD,MPH ,FIDSA,FSHEA, Dr Paul Gastro, tom lodise, and more, discuss key management strategies for clinicians and patients: contagionlive.com/view/advances-…

No #GIList is complete without a consult for “Colon Ischemia”! Join us tomorrow for the upcoming #ScopingSundays session to learn some pearls & share your tips & tricks! Moderated by Rashmi Advani, MD, ABOM & Maham Hayat, MD - & our Expert Guests Alex Perelman & Dr Paul Gastro!

So excited for this session with Maham Hayat, MD Alex Perelman Dr Paul Gastro !! When: 2PM EST TODAY. How: Click on the post below to follow through with the content and engage. This is ALL ON TWITTER (❌🎥, no link) Questions are open for 24 hours! #GITwitter

Experts Dr Paul Gastro Kevin Garey and Dr. Krishna Rao discuss guideline-directed prevention and treatment of recurrent #cdiff as well as antimicrobial interventions to reduce recurrence and improve outcomes bit.ly/3eBH7S9 #CME

Frequently answered questions on management of C difficile infection! #Cdiff #FMT authors.elsevier.com/a/1dICw5qq8QBs…

Congratulations to PACTGastroCenter’s Dr Paul Gastro on this well deserved accomplishment and for the tremendous contribution to the management of this ubiquitous disease

Join Dr Paul Gastro and I for an invigorating live virtual #CME on Jan 29th at 1645 CST on Patient-Centered Approaches to Treatment and Prevention of Clostridioides difficile. #Cdiff #FMT #Microbiome #antibiotics ACHL C DIFF FOUNDATION Journal of Gastrointestinal Infections achlcme.org/patient-center…

This Friday, 1/28 from 4:45 pm - 5:45 pm CST, join Dr Paul Gastro and Sahil Khanna, MBBS, MS, FACG, AGAF (he/him) as they review the latest data and clinical approaches to Clostridioides difficile infection (CDI). COMPLIMENTARY REGISTRATION: bit.ly/3rPentO #cdiff #virtualevent #gastroenterology

Next: a phase 3, DBRPCT in NEJM. Pts who had 3 or more episodes of C. difficile infection received SER-109 or placebo after standard-of-care antibiotic treatment. SER-109 was superior to placebo in reducing the risk of recurrent infection. nejm.org/doi/full/10.10… Dr Paul Gastro

With #DDW2022 just three days away, we’re discussing the potential impact of #microbiome therapeutics on patients. This is what gastroenterologist Dr Paul Gastro of Yale School of Medicine has to say on the topic! #DDWSeres

Away we go… back on #MedTwitter and heading to #DDW2022 JFK—> SAN Looking forward to catching up with old friends, educating and learning in person!